Mannkind (MNKD) Enterprise Value (2010 - 2026)
Mannkind's (MNKD) quarterly Enterprise Value came in at -$134.6 million in Q1 2026, up 26.15% year-on-year from -$106.7 million in Q1 2025, and up 21.78% on a QoQ basis from -$172.1 million in Q4 2025.
Mannkind (MNKD) Enterprise Value (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Enterprise Value data on file, last reported at -$134.6 million in Q1 2026.
- On a quarterly basis, Enterprise Value rose 26.15% year-over-year to -$134.6 million in Q1 2026; TTM through Mar 2026 was -$134.6 million, a 26.15% increase from a year earlier, with the FY2025 full-year figure at -$172.1 million, up 13.08% from the prior year.
- Enterprise Value for Q1 2026 stood at -$134.6 million, up from -$172.1 million in the prior quarter.
- Over the last five years, Enterprise Value for MNKD reached as high as -$134.6 million in Q1 2026 and fell as low as -$300.7 million in Q1 2024.
- Historically, Enterprise Value has averaged -$195.8 million across 5 years, with a median of -$172.1 million in 2025.
- Across the five-year window, Enterprise Value surged 41.33% in 2022 and tumbled 81.01% in 2024, its largest moves.
- Year by year, Enterprise Value stood at -$170.8 million in 2022, then plunged by 72.73% to -$295.1 million in 2023, then jumped by 32.91% to -$198.0 million in 2024, then grew by 13.08% to -$172.1 million in 2025, then grew by 21.78% to -$134.6 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$134.6 million in Q1 2026, -$172.1 million in Q4 2025, and -$260.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -134.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -134.61 Mn |
| Dec 31, 2025 | -172.09 Mn |
| Sep 30, 2025 | -260.78 Mn |
| Jun 30, 2025 | -179.73 Mn |
| Mar 31, 2025 | -182.28 Mn |
| Dec 31, 2024 | -197.99 Mn |
| Sep 30, 2024 | -252.32 Mn |
| Jun 30, 2024 | -248.49 Mn |
| Mar 31, 2024 | -300.73 Mn |
| Dec 31, 2023 | -295.10 Mn |
| Sep 30, 2023 | -141.02 Mn |
| Jun 30, 2023 | -144.35 Mn |
| Mar 31, 2023 | -166.14 Mn |
| Dec 31, 2022 | -170.85 Mn |
| Sep 30, 2022 | -165.04 Mn |
| Jun 30, 2022 | -154.16 Mn |
| Mar 31, 2022 | -162.40 Mn |
| Dec 31, 2021 | -204.12 Mn |
| Sep 30, 2021 | -139.05 Mn |
| Jun 30, 2021 | -162.49 Mn |